Brandupstrategy · Newsroom
HistoSpring Announces Issuance of U.S. Patent for Methods Predicting ER-Mediated DNA Damage
Novel technology provides a new approach for identifying estrogenic compounds associated with genomic instability and breast cancer riskJune 23, 2026